National Cancer Institute
Found 611 results for your search:
Total relevant funding to Ovarian Cancer for this search:
$95,328,626
Fiscal Year FY 2016
Cancer Type [Ovarian Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 611 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women 5R21CA194626-02 $190,313 $190,313 ORSULIC, SANDRA CEDARS-SINAI MEDICAL CENTER
2
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers 5R01CA184968-03 $509,161 $509,161 SIKIC, BRANIMIR STANFORD UNIVERSITY
3
(PQD5) Avatar-directed Treatment for Ovarian Cancer 5R01CA184502-03 $714,297 $714,297 WEROHA, SARAVUT MAYO CLINIC ROCHESTER
4
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci 5R21CA191725-02 $185,077 $61,075 FREEDMAN, MATTHEW DANA-FARBER CANCER INST
5
A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines 1F31CA203476-01 $34,274 $34,274 RADFORD, DAVID UNIVERSITY OF UTAH
6
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer 5R01CA175318-02 $354,563 $354,563 HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J.
7
A network platform to connect drug response and prognosis phenotypes for cancers 1R01CA196631-01A1 $395,911 $197,956 LI, HU MAYO CLINIC ROCHESTER
8
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer 5R00CA166228-04 $249,000 $249,000 GATZA, MICHAEL RBHS -CANCER INSTITUTE OF NEW JERSEY
9
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy 1R44CA206606-01 $995,814 $995,814 WILDS, DAN CYNVEC, LLC
10
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer 4R01CA168900-05 $332,000 $166,000 POWELL, DANIEL UNIVERSITY OF PENNSYLVANIA
11
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,229,987 $61,499 Sinha, Rashmi DCEG (NCI)
12
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $239,266 DANG, CHI UNIVERSITY OF PENNSYLVANIA
13
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $938 DANG, CHI UNIVERSITY OF PENNSYLVANIA
14
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $14,999 DANG, CHI UNIVERSITY OF PENNSYLVANIA
15
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $6,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
16
Activatable molecular cancer imaging probe ZIA BC 011512 $304,350 $30,435 Kobayashi, Hisataka CCR (NCI)
17
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research 4U24CA180921-04 $634,033 $126,807 JACOBSON, REBECCA UNIVERSITY OF PITTSBURGH AT PITTSBURGH
18
Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes 1R21CA209848-01 $195,098 $195,098 CHUNG, DONGJUN MEDICAL UNIVERSITY OF SOUTH CAROLINA
19
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer 7R01CA182832-03 $323,701 $323,701 MATEI, DANIELA NORTHWESTERN UNIVERSITY AT CHICAGO
20
Analysis of BRCA1 Recombination Functions 5R01CA095175-12 $328,700 $164,350 SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER
21
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells 5R01CA181543-03 $396,541 $396,541 BRUGGE, JOAN HARVARD MEDICAL SCHOOL
22
Anatomic Pathology Residency Program ZIE BC 011384 $1,014,935 $20,299 Barr, Frederic CCR (NCI)
23
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca 4R01CA172667-04 $334,803 $334,803 NOMURA, DANIEL UNIVERSITY OF CALIFORNIA BERKELEY
24
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID ZIA SC 004020 $2,321,426 $232,143 Berzofsky, Jay CCR (NCI)
25
Applying the Cloud Computing resources to efficiently and comprehensively accomplish genomic analysis of TCGA/ICGC samples 3R01CA172652-03S1 $64,000 $21,120 CHEN, KEN UNIVERSITY OF TX MD ANDERSON CAN CTR
26
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer 5R01CA135354-06 $380,000 $380,000 BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR
27
Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells 5R21CA187309-02 $171,399 $171,399 BARUA, ANIMESH RUSH UNIVERSITY MEDICAL CENTER
28
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute 1R50CA211108-01 $250,131 $125,066 MINDERMAN, HANS ROSWELL PARK CANCER INSTITUTE CORP
29
B7-H1 Signaling in Ovarian Cancer 4R01CA164122-05 $310,213 $186,128 CURIEL, TYLER UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
30
BASE PERIOD PERIOD OF PERFORMANCE: 3/1/2016 - 2/28/2017 DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC) 261201600007I $2,132,987 $533,247 UNKNOWN, UNKNOWN WESTAT INCORPORATED
31
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research ZIG BC 010856 $14,732,997 $736,650 Custer, Mary CCR (NCI)
32
Baylor College of Medicine Cancer Center 3P30CA125123-10S1 $118,016 $2,360 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
33
Baylor College of Medicine Cancer Center 3P30CA125123-10S2 $170,897 $3,418 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
34
Baylor College of Medicine Cancer Center 3P30CA125123-10S3 $118,875 $2,378 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
35
Baylor College of Medicine Cancer Center 3P30CA125123-10S4 $499,947 $9,999 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
36
Baylor College of Medicine Cancer Center 3P30CA125123-10S5 $134,220 $2,684 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
37
Baylor College of Medicine Cancer Center 5P30CA125123-10 $3,253,119 $65,062 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
38
BCDDP: Breast cancer detection demonstration project followup study - I ZIA CP010182-01030 $46,268 $9,254 Schairer, Catherine DCEG (NCI)
39
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance 1R01CA193249-01A1 $668,888 $668,888 LUTGENDORF, SUSAN UNIVERSITY OF IOWA
40
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $791,464 $39,573 Ambudkar, Suresh CCR (NCI)
41
Blocking NK cell shedding of CD16a to increase cancer cell killing 1R01CA203348-01 $443,533 $443,533 WALCHECK, BRUCE UNIVERSITY OF MINNESOTA
42
Bmi-1, a potential therapeutic target in ovarian cancer 7R01CA157481-05 $311,480 $311,480 BHATTACHARYA, RESHAM UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
43
BRCA1 Function in Post-Damage Nuclear Foci 2R01CA136512-06A1 $515,452 $257,726 LIVINGSTON, DAVID DANA-FARBER CANCER INST
44
Breast imaging studies in women at high genetic risk of breast cancer ZIA CP010145-07040 $31,798 $4,770 Loud, Jennifer DCEG (NCI)
45
Breast, Colorectal, and Ovary Cancer Clinical Validation Center 2U01CA152637-06 $1,011,430 $333,772 LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER
46
Building on the success of the adoptive immunotherapy of cancer ZIA BC 010763 $1,579,134 $157,913 Restifo, Nicholas CCR (NCI)
47
Building upon a tradition of excellence. The NCTN at Indiana University 5U10CA180795-03 $611,729 $18,352 MILLER, KATHY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
48
Cancer Center Support (CORE) Grant 3P30CA034196-31S1 $458,945 $119,326 LIU, EDISON JACKSON LABORATORY
49
Cancer Center Support (CORE) Grant 5P30CA034196-31 $2,100,000 $546,000 LIU, EDISON JACKSON LABORATORY
50
Cancer Center Support (CORE) Grant 3P30CA016672-41S1 $120,000 $10,800 DEPINHO, RONALD UNIVERSITY OF TX MD ANDERSON CAN CTR
Total relevant funding to Ovarian Cancer for this search: $95,328,626
Showing 1 - 50 of 611 results
Go to top